551 related articles for article (PubMed ID: 34831399)
1. Role of AHR Ligands in Skin Homeostasis and Cutaneous Inflammation.
Fernández-Gallego N; Sánchez-Madrid F; Cibrian D
Cells; 2021 Nov; 10(11):. PubMed ID: 34831399
[TBL] [Abstract][Full Text] [Related]
2. Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor-modulating agent.
Bissonnette R; Stein Gold L; Rubenstein DS; Tallman AM; Armstrong A
J Am Acad Dermatol; 2021 Apr; 84(4):1059-1067. PubMed ID: 33157177
[TBL] [Abstract][Full Text] [Related]
3. Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis.
Furue M; Hashimoto-Hachiya A; Tsuji G
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683543
[TBL] [Abstract][Full Text] [Related]
4. A New Insight into the Potential Role of Tryptophan-Derived AhR Ligands in Skin Physiological and Pathological Processes.
Szelest M; Walczak K; Plech T
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499346
[TBL] [Abstract][Full Text] [Related]
5. Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans.
Smith SH; Jayawickreme C; Rickard DJ; Nicodeme E; Bui T; Simmons C; Coquery CM; Neil J; Pryor WM; Mayhew D; Rajpal DK; Creech K; Furst S; Lee J; Wu D; Rastinejad F; Willson TM; Viviani F; Morris DC; Moore JT; Cote-Sierra J
J Invest Dermatol; 2017 Oct; 137(10):2110-2119. PubMed ID: 28595996
[TBL] [Abstract][Full Text] [Related]
6. Anti-Inflammatory and Pro-Differentiating Properties of the Aryl Hydrocarbon Receptor Ligands NPD-0614-13 and NPD-0614-24: Potential Therapeutic Benefits in Psoriasis.
Cardinali G; Flori E; Mastrofrancesco A; Mosca S; Ottaviani M; Dell'Anna ML; Truglio M; Vento A; Zaccarini M; Zouboulis CC; Picardo M
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299118
[TBL] [Abstract][Full Text] [Related]
7. Role of Aryl Hydrocarbon Receptor Activation and Autophagy in Psoriasis-Related Inflammation.
Kim HR; Kang SY; Kim HO; Park CW; Chung BY
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32235789
[TBL] [Abstract][Full Text] [Related]
8. Role of Aryl Hydrocarbon Receptor Activation in Inflammatory Chronic Skin Diseases.
Napolitano M; Fabbrocini G; Martora F; Picone V; Morelli P; Patruno C
Cells; 2021 Dec; 10(12):. PubMed ID: 34944067
[TBL] [Abstract][Full Text] [Related]
9. Natural Compounds Tapinarof and
Tsuji G; Hashimoto-Hachiya A; Matsuda-Taniguchi T; Takai-Yumine A; Takemura M; Yan X; Furue M; Nakahara T
Front Immunol; 2022; 13():745997. PubMed ID: 35663970
[TBL] [Abstract][Full Text] [Related]
10. Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical review.
Silverberg JI; Boguniewicz M; Quintana FJ; Clark RA; Gross L; Hirano I; Tallman AM; Brown PM; Fredericks D; Rubenstein DS; McHale KA
J Allergy Clin Immunol; 2023 Dec; ():. PubMed ID: 38154665
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of the aryl hydrocarbon receptor in patients with chronic inflammatory skin diseases.
Kim HO; Kim JH; Chung BY; Choi MG; Park CW
Exp Dermatol; 2014 Apr; 23(4):278-81. PubMed ID: 24521260
[TBL] [Abstract][Full Text] [Related]
12. Lead optimization of aryl hydrocarbon receptor ligands for treatment of inflammatory skin disorders.
Rikken G; Smith KJ; van den Brink NJM; Smits JPH; Gowda K; Alnemri A; Kuzu GE; Murray IA; Lin JM; Smits JGA; van Vlijmen-Willems IM; Amin SG; Perdew GH; van den Bogaard EH
Biochem Pharmacol; 2023 Feb; 208():115400. PubMed ID: 36574884
[TBL] [Abstract][Full Text] [Related]
13. Functions of the aryl hydrocarbon receptor in the skin.
Esser C; Bargen I; Weighardt H; Haarmann-Stemmann T; Krutmann J
Semin Immunopathol; 2013 Nov; 35(6):677-91. PubMed ID: 23949496
[TBL] [Abstract][Full Text] [Related]
14. Reduction of CC-chemokine ligand 5 by aryl hydrocarbon receptor ligands.
Morino-Koga S; Uchi H; Tsuji G; Takahara M; Kajiwara J; Hirata T; Furue M
J Dermatol Sci; 2013 Oct; 72(1):9-15. PubMed ID: 23810773
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor (AhR) a possible target for the treatment of skin disease.
Napolitano M; Patruno C
Med Hypotheses; 2018 Jul; 116():96-100. PubMed ID: 29857917
[TBL] [Abstract][Full Text] [Related]
16. [The aryl hydrocarbon receptor as the target structure for new drugs in psoriasis and atopic dermatitis].
Merk HF
Hautarzt; 2019 Dec; 70(12):942-947. PubMed ID: 31728551
[TBL] [Abstract][Full Text] [Related]
17. IL-24 Negatively Regulates Keratinocyte Differentiation Induced by Tapinarof, an Aryl Hydrocarbon Receptor Modulator: Implication in the Treatment of Atopic Dermatitis.
Vu YH; Hashimoto-Hachiya A; Takemura M; Yumine A; Mitamura Y; Nakahara T; Furue M; Tsuji G
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321923
[TBL] [Abstract][Full Text] [Related]
18. Host/microbiota interactions-derived tryptophan metabolites modulate oxidative stress and inflammation via aryl hydrocarbon receptor signaling.
Tan YQ; Wang YN; Feng HY; Guo ZY; Li X; Nie XL; Zhao YY
Free Radic Biol Med; 2022 May; 184():30-41. PubMed ID: 35367341
[TBL] [Abstract][Full Text] [Related]
19. Role of AhR/ARNT system in skin homeostasis.
Furue M; Takahara M; Nakahara T; Uchi H
Arch Dermatol Res; 2014 Nov; 306(9):769-79. PubMed ID: 24966027
[TBL] [Abstract][Full Text] [Related]
20. The Role of Aryl Hydrocarbon Receptor in the Pathogenesis and Treatment of Psoriasis.
Lin X; Meng X; Lin J
J Cutan Med Surg; 2024; 28(3):276-286. PubMed ID: 38497283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
